NanoInnovations was founded in 2014 by Dr. Huma Jafry subsequent to her participation in the Wendy Schmidt Ocean Health xPrize Competition. The company has since focused on the research, development, and commercialization of smart nanosensors in conjunction with Machine Learning for healthcare analytics. The company’s platform technology has been used on bio-fluids such as sweat and saliva for work related to diabetes and heart failure.
Our vision is to empower customers with real-time information to enable efficient patient care and healthcare management. We use versatile nanosensor based platforms to gather multivariate data which can then be analyzed in real-time with AI algorithms to generate useful patient specific diagnostic and prognostic outputs.
Dr. Huma Jafry is the founder and CEO of NanoInnovations and works on the development and commercialization of smart nanosensors and algorithims for health care prognostics and diagnostics. She has earned her Ph.D and postdoctoral fellowship in Nanomaterials Chemistry from Rice University in Houston, TX. Dr. Jafry has worked on projects focused on the development of nanocomposites for applications in water purification systems, self-cleaning fabrics, and heat abatement and radiation attenuation nanotechnologies for the space industry. Prior to starting NanoInnovations, Dr. Jafry participated in the Ocean Health xPrize competition and the technology developed led to the formation of the company. Her undergraduate degree is in Economics and Computer Science from Mount Holyoke College in MA.
She currently serves on the board of the Health Science Museum in Houston, and the Sugar Land Discovery Center, and serves as a volunteer within the Ismaili community. She has spoken about applications of nanotechnology at several places, including for TEDx Sugar Land.
Shayne Phillips has been working in the intellectual property (IP) arena for over twenty years, particularly in the areas of IP-related competitive intelligence and technical patent and nonpatent literature searching. Ms. Phillips began her career at Procter & Gamble (P&G) in Cincinnati, Ohio, working as a Technical Assistant in Corporate New Ventures (a group tasked with evaluating outside technology for the entirety of P&G). She then moved to the IP-practice group of Dinsmore & Shohl (also in Cincinnati), working as a Technical Consultant, providing both patent application prosecution support and IP litigation assistance. In 2000 Ms. Phillips moved to Columbus, Ohio, and began work at Chemical Abstracts Service (CAS) as an Editorial Analyst in the Mammalian Hormones Document Indexing Group of the Biochemistry Department of CAS’ Editorial Division. In 2002 she transitioned to the role of Applications Specialist at CAS, specializing in advanced STN training, focusing on protein and gene sequence searching in particular. Following her tenure at CAS, Ms. Phillips moved to Halliburton in Houston, Texas, working in their Intellectual Asset Management group as both the head of IP Competitive Intelligence and as a Senior Patent Liaison for the Cementing and Multichem Product Service Lines. Currently, Shayne is both the Founder of, and a Managing Member of, Six Points Consulting, LLC, based in the Houston metro area. Ms. Phillips holds a Bachelor of Science degree in Biology from Youngstown State University, a Master of Science degree in Biochemistry from the University of Cincinnati, and a Master of Business Administration degree from Capital University in Columbus, Ohio. She is also a registered US Patent Agent.
Huma Jafry, Ph.D
Founder and CEO
Rahil is the Chairman & CEO of Rushmore Energy, a Houston based energy company with presence in seven states across the United States. Prior to founding Rushmore Energy, Rahil helped launch and grow a start-up into one of the largest independent energy providers in the State of Texas before it was acquired by a publicly traded company in 2011.
Previously, Rahil led deal structuring for a large private equity fund for its successful bid on a $1 Billion portfolio of electricity generation assets. He has also held senior positions at UBS Warburg and at Enron in Houston, London, and New York. At UBS, Rahil was responsible for establishing the bank’s energy derivative trading business with hedge funds across the US and Europe. During his tenure at Enron, Rahil was involved with several strategic initiatives, helping establish the company’s derivatives trading business for Continental Europe, and co-founding EnronOnline, the company’s proprietary trading platform that later became the largest web-based trading platform in the world with $940 billion in commodity transactions conducted over two years.
Rahil attended the University of Texas at Austin, where he earned his Bachelor of Arts in Economics and a Master of Science in Technology Commercialization. He has conducted research on technology commercialization, public-private partnership models, and smart city projects at the IC2 Institute at the University of Texas at Austin and the Austin Technology Incubator. Rahil has also completed coursework in Corporate Finance at the London Business School and in Strategic Negotiations at the Harvard Kennedy School. He has lectured at the Columbia University Graduate School of Business and has been interviewed by various business and academic publications, including a case study at the Harvard Business School.
Rahil is an active member of the Young Presidents’ Organization (YPO) and has served on the Boards of the YPO Deal Network, YPO Global Diplomacy Network, the Aga Khan Economic Planning Board for the United States. He currently serves on the Board of the American Ismaili Chamber of Commerce (AICC).
Dr. Asif Khan
Dr. Asif Khan is an internist with specialty in infectious diseases and addiction medicine. He is the founder and CEO of Northwest Integrated Health, an integrated treatment model for behavioral health and physical health integration in greater Seattle area. He is also the founder and CEO of Physician Office Laboratory Specialists (POLS), that can manage and help start High complexity laboratories in all 50 states. Dr. Khan is also the laboratory director for five High Complexity Laboratories. He is clinical faculty at University of Washington’s Department of Family Medicine and has his MBA from University of Washington.
Dr. Khan is on the board of directors at Medtest Holdings, one of the portfolio companies at Enhanced Equity Fund (EEF), and for Key-Opinion-Leader (KOL) for In-vitro Diagnostics with Mindray North America. He is also a board member for Washington Association of Addiction and Alcohol Programs, and a member of Accountable Communities of Health Integration committee for Pierce county Washington. He is the medical director for Pierce county medical reserve corps and Pierce County Alliance. He is also a charter member of the local Lions Club in Tacoma, Washington.